Angiotensin-converting enzyme (ACE) was isolated from detergent-derived extracts of human intestinal brush-border membranes (BBMs) by immunoprecipitation using a monoclonal antibody. Analysis 
INTRODUCTION
Among the most important functions of angiotensin Iconverting enzyme (ACE) (kininase II; EC 3.4.15.1) is its role in the regulation of blood pressure; ACE hydrolyses angiotensin I to the potent vasoconstrictor angiotensin II, and converts the vasodilator bradykinin into an inactive peptide (Yang et al., 1970; Erd6s, 1975; Skeggs et al., 1976; Soffer, 1981; Patchett & Cordes, 1985) . ACE has been identified in many tissues, for example lung, kidney, areas of the brain, and gut epithelium, with the lung being the site of the conversion of angiotensin I into angiotensin II (Ng & Vane, 1967) . By virtue of this wide tissue distribution, ACE appears to have several important physiological functions other than its participation in blood pressure regulation.
ACE is a glycoprotein that consists of a single subunit of an apparent Mr varying between 130000 and 180000 (Erd6s, 1975; Soffer, 1976) . The difference in the M, is presumably due to variations in the glycosylation pattern of the enzyme or to differences in the methods used in the estimation of M,.
In most of the tissues investigated striking similarities were discerned in the physiochemical, immunological and catalytic properties of the enzyme (Soffer, 1981) . This is further supported by cloning of cDNAs encoding ACE from different species and tissues. Mouse kidney ACE, for example, displays approx. 83 % identity to human endothelial ACE in both nucleic-acid and amino-acid sequences, with the catalytic regions of both enzymes being the most highly conserved (Soubrier et al., 1988; Bernstein et al., 1989 ). An interesting feature of the ACE protein is its organization in two large homologous domains, each comprising a potential catalytic site (Soubrier et Bernstein et al., 1989) . Each of these regions is almost half the size of the whole polypeptide. In light of these observations it has been suggested that the ACE gene has arisen by duplication of a common precursor gene.
Testicular ACE, on the other hand, is characterized by a shorter polypeptide of approx. 100000-Mr (El Dorry et al., 1982a,b; Lanzillo et al., 1985; Erdos & Skidgel, 1987) and a different pattern of expression, since it first appears at puberty (Cushman & Cheung, 1971a) . Cloning of a cDNA encoding this form from the human and rabbit testis (Ehlers et al., 1989; Kumar et al., 1989; Lattion et al., 1989) indicated that its aminoacid sequence is approximately half that of the endothelial or kidney enzyme and shows striking sequence similarities (almost 90%; Kumar et al., 1989) with the C-terminal half of the endothelial enzyme (and probably also with the kidney enzyme). In contrast with the endothelial enzyme, however, testicular ACE contains one active catalytic centre. The fact that the testicular enzyme is as active as the endothelial protein suggests that one of the two catalytic sites of the endothelial enzyme, the counterpart of the testicular site, is responsible for the conversion of angiotensin I into angiotensin II. In accordance with these findings the consensus opinion has emerged that endothelial (or lung) ACE has resulted from gene duplication, whereby testicular ACE corresponds to an ancestral form of the non-duplicated gene.
ACE is found as a membrane-bound enzyme and as a circulating molecule in body fluids (Das et al., 1977) . The membrane-bound forms, e.g. in endothelial cells, testis or kidney, are thought to be anchored in the membrane via a hydrophobic segment near the C-terminus (Hooper et al., 1987; Soubrier et al., 1988; Bernstein et al., 1989; Kumar et al., 1989 on the observations that secreted forms of ACE could be released merely by incubating the membranes at 37°C (Hooper et al., 1987) or following tissue homogenization (Igic et al., 1972; Nakajima et al., 1973; Patchett & Cordes, 1985) , an endogenous mechanism has been proposed for the generation of secreted ACE from membrane-bound ACE forms.
ACE has been also identified in intestinal epithelial cells. Here it was found associated with the microvilli in high concentration (Ward et al., 1980; Defendini et al., 1983) and is assumed to play a role in fluid and sodium absorption (Crocker & Munday, 1970) or to participate in the terminal steps of digestion of dipeptides in the intestinal lumen (Yoshioka et al., 1987) . However, several aspects of its structure, function and biosynthesis remain unknown. As an essential step towards a better understanding of the role and function of ACE in the intestinal brush-border membrane (BBM) and towards unravelling the molecular mechanisms underlying its secretion I investigated, in this paper, the subunit and quaternary structure of ACE in the human intestinal brush border, analysed its association with the membrane, and identified its precursor and mature forms in biosynthetically labelled intestinal tissue. (Hauri et al., 1985) and were used in the form of ascites prepared from hybridoma-bearing pristane-primed Balb/c mice. The specificities of the antibodies were assessed by enzyme-activity measurements of immunoisolated antigens (Hauri et al., 1985) and were confirmed in our laboratory by following the same experimental protocol. Thus the antigenic material precipitated by the hybridoma HBB 3/264/18 revealed ACE activity as assessed by the method of Cushman & Cheung (1971b) Intestinal biopsy specimens were biosynthetically labelled, essentially as described by Naim et al. (1987 Naim et al. ( , 1988a . In brief, each biopsy specimen was placed on stainless-steel grids in organ culture dishes (Browning & Trier, 1969) and labelled with 1 ml of an incubation medium containing methionine-free RPMI 1640, streptomycin (100 ,tg/ml), penicillin (100 units/ml), 10 % (v/v) dialysed fetal calf serum (FCS) and 150 ,tCi of [35S]methionine.
EXPERIMENTAL
Labelling was performed for both 30 min and 4 h. After labelling, the biopsy specimens were cooled to 4 'C, washed three times in cold PBS and homogenized with a Teflon-glass homogenizer in 1 ml of buffer A [25 mM-Tris/HCl (pH 8.1), 50 mM-NaCl, 1 mm-PMSF, 1 ,ug of pepstatin, 5 ,ug of leupeptin, 17.4 jtg of benzamidine, 5 ,ug of antipain and 1,ug of aprotinin]. The homogenates were either further processed directly for immunoprecipitation or kept frozen at -20 'C until used. Preparation of right-side-out and inside-out brush-border vesicles Right-side-out BBMs were purified by lectin affinity chromatography using wheat germ agglutinin. Briefly, 2 ml of BBM [1 mg/ml; FlI fraction (Sterchi & Woodley, 1980) ] was incubated with 2 ml of the wheat-germ-agglutinin-Sepharose beads for 2 h at 4 'C. The beads were washed four times with 25 mM-Tris/HCl, pH 7.5/50 mM-NaCl (buffer B) and eluted for 1 h at 4 'C with 2 ml of buffer B supplemented with 2.5 % (w/v) N-acetylglucosamine. The eluates were centrifuged (25 000 g, 30 min) and the pellet resuspended in 1 ml of buffer B. Hydrophobic labelling of these vesicles with 100 ,sCi of 1251-labelled TID was performed according to Liischer et al. (1985) . The labelled membranes were spun at 100000 g for 20 min, resuspended in 2 ml of buffer B (see above) and then divided into two equal parts. One part was solubilized in 0.5% Triton-100 and 0.5 % sodium deoxycholate (final concentrations) and immunoprecipitated with anti-ACE antibodies. The other part was treated with trypsin [1: 10 (w/w) trypsin/protein] at 37 'C for 1 h. The reaction was stopped by the addition of a 4-fold excess, over trypsin, of soybean trypsin inhibitor. The membranes were then centrifuged at 100000 g for 1 h at 4 'C and the supernatant was immunoprecipitated with anti-ACE antibodies.
Inside-out membrane vesicles were purified as follows. Four biopsy samples (about 20-40 mg wet wt.) were labelled for 6 h 1992 with [35S]methionine and homogenized in buffer A. BBMs were purified by subcellular fractionation using CaCl2 (Naim et al., 1988a) and the pellet homogenized in buffer B. These homogenates contain both inside-out and right-side-out vesicles. The homogenates were then depleted of the right-side-out vesicles by absorption on a wheat-germ-agglutinin-conjugated Sepharose 4B column. After the first run the column was eluted with 2.5 % (w/v) N-acetylglucosamine. The inside-out vesicles, which were recovered as unbound material in the column flow-through, were passed once again through the column to ensure complete depletion of right-side-out vesicles. Finally, half of the inside-out vesicles was treated with 50 ,ug of trypsin at 37°C for 1 h and the other half was incubated under the same conditions without trypsin. Tryspin-treated and non-treated vesicles were centrifuged at 100000 g for 1 h at 4°C, the pellets were solubilized and then immunoprecipitated with anti-ACE antibodies.
Sucrose-gradient centrifugation
Biopsy samples were biosynthetically labelled for 6 h with [35S]methionine, homogenized and subcellularly fractionated, using CaCl2, into BBMs and intracellular/basolateral membranes (IBLMs) according to Schmitz et al. (1973) . The BBM fraction, corresponding to four biopsy samples, was solubilized in 500 ,ul of 6 mM-dodecyl-,f-m-maltoside, 50 mM-Tris/HCl, 100 mmNaCl, pH 7.5, and a mixture of protease inhibitors (see above) for 1 h at 4 'C. After centrifugation at 100000 g for 1 h at 4 'C the supernatant was loaded on to a sucrose gradient that had been made on the top of 600 Isl of 50 % (w/v) sucrose cushion and consisted of 10-30 % (w/v) sucrose, 50 mM-Tris/HCl, 100 mM-NaCl, 6 mM-dodecyl-fi-m-maltoside, pH 7.5. The gradient was centrifuged at 105 000 g for 16 h at 4 'C and divided into 16 equal parts (approx. 640 ,ul/fraction), with fraction 1 representing the bottom of the gradient. The fractions were diluted with an equal volume of water and the pH was adjusted to 8.0 before immunoprecipitation with a mixture of anti-ACE and anti-ApN antibodies. Finally, the immunoprecipitates were analysed by SDS/PAGE on 5 % gels.
Other procedures
Preparation of BBM vesicles [fraction II (FIT)] from smallintestinal mucosa was performed according to the CaCl2-fractionation method of Schmitz et al. (1973) and the modification by Sterchi & Woodley (1980) . Subcellular fractionation of biosynthetically labelled biopsy specimens into BBMs and IBLMs was according to Naim et al. (1988a) . Chemical cross-linking of BBMs using DSP in dimethyl sulphoxide was performed as described by Naim et al. (1988b) . Cross-linking experiments were also performed using several other homobifunctional reagents such as DMS, DTBP and DSS. The results with these reagents were similar to those obtained with DSP and will therefore not be reported here. Immunoprecipitations were essentially performed according to Naim et al. (1987) . Digestion of 35S-labelled immunoprecipitates with endo H was performed as previously described (Naim et al., 1987 , and references therein); the endo H concentration used was 3 mi.u. Digested proteins were recovered by precipitation with trichloroacetic acid, 15 % (w/v) final concentration and the pellets were washed twice with ice-cold acetone and kept at -20 'C.
One-dimensional electrophoresis was conducted in 4 %, 5 % or 6% polyacrylamide slab gels containing 0.1 % SDS by the method of Laemmli (1970) .
RESULTS AND DISCUSSION Molecular forms of human intestinal ACE
To assess the subunit structure of ACE in the intestinal BBM, we isolated ACE from detergent-derived extracts of BBMs by immunoprecipitation with a monoclonal antibody conjugated to Protein A-Sepharose. The immunoprecipitates were further analysed by SDS/PAGE. To identify precursor and mature forms of ACE and assess its pattern of glycosylation, biopsy samples were biosynthetically labelled with [35S]methionine for 30 min or 4 h and homogenized. The detergent-derived extracts were immunoprecipitated with anti-ACE antibodies. The precursor and mature forms of ACE were identified by probing for their endo H sensitivity. Within 30 min of labelling ACE was detected as a polypeptide of apparent Mr 174000 (Fig. 2 , lane 1) which was sensitive to endo H treatment (Fig. 2, lane 2) , indicating that it represents the mannose-rich precursor of ACE. After 4 h of labelling a band of apparent M, 184000 was revealed (Fig. 2, lane 3) . This band was practically resistant to treatment with endo H (Fig. 2, lane 4) indicating that it carries complex types of oligosaccharides and has been processed in the Golgi apparatus. Together with the identification of the 184000-M, protein in BBMs (see Fig. 1 cross-linked with the homobifunctional lysine-specific reagent DSP to retain their native membrane organization. After crosslinking, the membranes were solubilized with Triton X-100 and ACE and a control brush-border peptidase, ApN, were immunoprecipitated and analysed by SDS/PAGE. Fig. 3(a) demonstrates that no difference in the electrophoretic pattern of ACE could be detected in the presence (lane 2) or absence (lane 1) of the crosslinking reagent. By contrast, significant changes in the band pattern of the control glycoprotein, ApN, were observed on cross-linking with DSP (Fig. 3b) . In the absence of the crosslinker ApN is characterized by one major band of apparent Mr 160000 and a faint band of apparent Mr 265 000 (Fig. 3b, lane 1) . On cross-linking the staining intensity of the 265 000-Mr protein increases significantly, and a faint, high-molecular-mass band additionally appears (indicated by the arrow) with a concomitant decrease in the staining intensity of the 160 000-Mr protein (Fig. 3b, Fig. 4 shows that ACE was found exclusively in fraction 7 (Fig. 4, lane 4) . The control glycoprotein, ApN, which has an apparent Mr of 160000 and therefore is slightly smaller than ACE, appeared mainly in fraction 9 and to a lesser extent in fraction 10 (Fig. 4, lanes 6 and 7) The gradient was calibrated using the proteins /3-amylase (Mr 200000) and apoferritin (Mr 450000). ,3-Amylase was revealed to be mainly in fraction 7, while apoferritin was found in fraction 12. The fact that ApN appears in fraction 9 of the gradient, i.e. between 8-amylase and apoferritin, is compatible with a homodimeric structure of the protein (2 x 160000 = 320000-Mr). The possibility that ApN is also assembled in the membrane as a trimeric (3 x 160000 = 480000-Mr) or tetrameric (4 x 160000 = 640000-Mr) protein could be excluded since these forms should be found in gradient fractions that have a comparable density to apoferritin (trimeric ApN) or an even higher density than apoferritin (tetrameric ApN), and this was not the case. Collectively, the cross-linking and the gradient-centrifugation experiments demonstrate that ApN is a dimeric protein. On the other hand, the density-gradient-centrifugation experiments show that ACE is assembled in the BBM as a monomer since: (i) dimeric ACE (2 x 184000 = 368 000-Mr) should be recovered in gradient fractions of density similar to dimeric ApN (320000-Mr), i.e. fraction 9, or even of slightly higher density, i.e. fraction 10; and (ii) ACE is revealed in the same fraction as the control protein ,-amylase (Mr 200000).
Mode of association of ACE with the membrane
The mode of attachment of intestinal ACE to the membrane was examined by performing hydrophobic labelling of intact BBM vesicles using 125I-TID. TID is a photolabel that exclusively reacts with the hydrophobic core of membrane proteins (Spiess et al., 1982) . Right-side-out vesicles were enriched from BBMs by chromatography using wheat-germ-agglutinin-Sepharose beads and were subsequently labelled with TID. Fig. 5(a) shows that ACE was immunoprecipitated from detergent-derived extracts of TID-labelled vesicles (lane 2), indicating the presence of a hydrophobic segment in ACE that is accessible to the label. To examine whether the label is specifically confined to a hydrophobic domain in the molecule, labelled vesicles were treated with trypsin, centrifuged and the supernatant immunoprecipitated with anti-ACE antibodies. As shown in Fig. 5(a) , this treatment resulted in the failure of ACE antibodies to immunoprecipitate radioactively labelled ACE bands from the supernatant of trypsin-treated vesicles (lane 1). By contrast, Coomassie Blue staining of the same gel revealed strongly stained bands in the supernatant of trypsin-treated vesicles (Fig. Sb, lane  1 ; note that lane 1 in Fig. 5b is the Coomassie Blue-stained lane 1 in Fig. Sa) and in the pellet of non-treated samples (Fig. Sb,  lane 2) . Moreover, the size of trypsin-treated ACE was slightly smaller (about 5000-Mr) than the non-treated sample. Therefore the failure to detect radioactively labelled ACE in the supernatant of trypsin-treated samples (Fig. Sa, lane 1) is not the consequence of a substantial degradation of ACE by trypsin. The results are indicative of the existence of a domain in the ACE molecule that is accessible to hydrophobic probes. Since a major part of the molecule (Mr 179000) was cleaved from the membrane by trypsin treatment, released into the supernatant as a watersoluble molecule and not labelled by the hydrophobic label, I conclude that the label is confined to a hydrophobic domain in ACE that is responsible for its anchorage in the membrane. Furthermore I wanted to determine whether ACE possesses a cytoplasmic tail and has therefore a transmembraneous orientation. One approach is to separate inside-out membrane vesicles from total BBMs and to subject them to treatment with trypsin. A removal of a putative cytoplasmic tail by trypsin would be consistent with a reduction in the apparent Mr of ACE, which could be electrophoretically detected. For this purpose biopsy samples were labelled with [35S]methionine for 6 h. The biopsy homogenates were subcellularly fractionated into IBLMs and BBMs. Immunoprecipitation of part of these membrane fractions with anti-ACE antibodies revealed two bands in the IBLM fraction having apparent Mrs of 174000 and 184000 (Fig. 6a , lane 2) and one predominant band in the BBM fraction of apparent Mr 184000 (Fig. 6a, lane 1) . The BBMs containing the 184000-Mr proteins were passed through a lectin column to separate right-side-out from inside-out vesicles. The right-sideout vesicles are those retained by the lectin column due to the surface expression of glycosylated proteins, while inside-out vesicles expose existing cytoplasmic tails of glycoproteins and are therefore not retained by the column and instead are recovered in the column flow-through fractions. The inside-out vesicles were then digested with trypsin and subjected to immunoprecipitation with anti-ACE antibodies. Fig. 6(b) shows that trypsin-treated inside-out vesicles contain an ACE band that has a slightly reduced apparent Mr (lane 2) in comparison with ACE isolated from non-trypsin-treated vesicles (lane 1). The results therefore provide evidence for the existence of a cytoplasmic portion of ACE that is cleaved off during trypsin treatment. The reduction in the apparent Mr by approx. 3000 is consistent with the proposed length of the cytoplasmic tail of ACE deduced from cDNA cloning of the endothelial enzyme (Soubrier et al., 1988) .
In view of the fact that ACE possesses a membrane-anchoring domain and a cytoplasmic tail, we conclude that membranebound intestinal ACE has a transmembraneous orientation. The difference in Mr of about 5000 between ACE and hydrophilic ACE that was generated by trypsin treatment of right-side-out vesicles probably represents the size of the cytoplasmic tail together with the hydrophobic stretch that spans the lipid bilayer. Hooper et al. (1987) have also observed that the membranebound form of pig kidney ACE has an Mr approx. 5000 greater than that of trypsin-treated or hydrophilic ACE forms.
Concluding remarks
In this paper I investigated the biosynthesis, subunit and Vol. 286 quaternary structure and membrane association of ACE in the human small intestine.
I could demonstrate that ACE is synthesized as a single-chain polypeptide precursor that matures to the final BBM form (Mr 184000). ACE does not contain intermolecular disulphide bridges and is assembled in the BBM as a monomeric glycoprotein, in contrast with ApN which exists as a homodimeric glycoprotein. Finally, ACE is associated with the BBM via a hydrophobic segment that spans the membrane at least once and has a transmembraneous orientation. My results lend strong support to cloning data which have proposed that membrane-bound ACE in various species and tissues has a hydrophobic segment near its C-terminus that might function as a membrane anchor (Soubrier et al., 1988; Bernstein et al., 1989; Ehlers et al., 1989; Kumar et al., 1989) and support the notion that ACE is not attached to the membrane by a glycophospholipid anchor (Hooper et al., 1987) .
I do not know whether ACE is also found in a monomeric form in other tissues and species. Most of the brush-border components so far characterized are known to be assembled in the BBM as homo-or hetero-or homoheterodimers (Cowell et al., 1986; Naim et al., 1988b; Danielsen, 1990; Jascur et al., 1991 ; for reviews see Kenny & Maroux, 1982; Semenza, 1986) . In many cases, dimerization or oligomerization of these proteins have been shown to be important for intracellular transport, since it occurs before cell surface insertion (Danielsen, 1990; Jascur et al., 1991) . This is consistent with current concepts of biosynthesis and processing of membrane and secretory proteins that have assigned a crucial role to oligomerization in intracellular protein transport (Gething et Bernstein et al., 1989; Chen & Riordan, 1990) , monomeric ACE forms pseudodimers that are transport competent.
